{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:59Z","timestamp":1789842899856,"version":"4.0.1"},"reference-count":15,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Statins are a group of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors aimed at reducing cholesterol synthesis. Since their discovery in 1970, their use has exponentially increased, becoming a regular preventive treatment for cardiovascular diseases. Among their most common adverse effects are myopathies, with the most severe being autoimmune necrotizing myopathy. We present a case of a woman in her 70s, with high cardiovascular-risk comorbid conditions, including autoimmune hypothyroidism, type 2 diabetes, arterial hypertension, and dyslipidemia. After 5 years on atorvastatin, she developed proximal limb weakness and elevated creatine kinase and creatine kinase-MB levels. A muscle biopsy showed autoimmune necrotizing myopathy and blood work confirmed positive 3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies. Based on these findings, a diagnosis of statin-associated autoimmune necrotizing myopathy was made. In this case, treatment with intravenous immunoglobulin and rituximab resulted in complete remission.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf037","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:26:50Z","timestamp":1744367210000},"source":"Crossref","is-referenced-by-count":2,"title":["Remission of Statin-associated Autoimmune Necrotizing Myopathy With Sequential Immunotherapy: A Well-studied Patient"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7323-0582","authenticated-orcid":false,"given":"Francisco J","family":"G\u00f3mez-P\u00e9rez","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Lipid Metabolism, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-295X","authenticated-orcid":false,"given":"Erwin","family":"Chiquete-Anaya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G","family":"Moncayo-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Lipid Metabolism, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1983-0384","authenticated-orcid":false,"given":"Armando","family":"Gamboa-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"Aguilar-Salinas","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Lipid Metabolism, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"},{"name":"Research direction, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"},{"name":"Research Unit for the Study of Metabolic diseases, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Lipid Metabolism, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"},{"name":"Research Unit for the Study of Metabolic diseases, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"10","key":"2025041110174981500_luaf037-B1","first-page":"e30080","article-title":"High-intensity statin with severe consequences: a case of non-autoimmune rosuvastatin-induced myonecrosis","volume":"14","author":"Hassan","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"2025041110174981500_luaf037-B2","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/jcsm.12960","article-title":"Step-by-step diagnosis and management of the nocebo\/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)","volume":"13","author":"Penson","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"2025041110174981500_luaf037-B3","first-page":"257","article-title":"Immune-mediated necrotizing myopathy due to statins exposure","volume":"37","author":"Villa","year":"2018","journal-title":"Acta Myol"},{"issue":"2","key":"2025041110174981500_luaf037-B4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00296-022-05230-0","article-title":"Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins","volume":"43","author":"Khan","year":"2022","journal-title":"Rheumatol Int"},{"key":"2025041110174981500_luaf037-B5","article-title":"A tough pill to swallow: two cases of statin-induced necrotizing autoimmune myopathy manifesting as dysphagia and transaminitis","volume":"11","author":"Chaudhry","year":"2023","journal-title":"SAGE Open Med Case Rep"},{"issue":"11","key":"2025041110174981500_luaf037-B6","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.3390\/jcm9113454","article-title":"Efficacy and safety of high-dose immunoglobulin-based regimen in statin-associated autoimmune myopathy: a multi-center and multi-disciplinary retrospective study","volume":"9","author":"Treppo","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"2025041110174981500_luaf037-B7","first-page":"c62","article-title":"Correction: a case of suspected statin-related delayed onset necrotizing myositis","volume":"14","author":"Smirlis","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"2025041110174981500_luaf037-B8","doi-asserted-by":"crossref","first-page":"e234805","DOI":"10.1136\/bcr-2020-234805","article-title":"Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin","volume":"13","author":"G\u00fcng\u00f6r","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2025041110174981500_luaf037-B9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12026-016-8867-x","article-title":"Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure","volume":"65","author":"Shovman","year":"2016","journal-title":"Immunol Res"},{"issue":"3","key":"2025041110174981500_luaf037-B10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2025041110174981500_luaf037-B11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.24541","article-title":"Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy","volume":"52","author":"Limaye","year":"2014","journal-title":"Muscle Nerve"},{"issue":"12","key":"2025041110174981500_luaf037-B12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3949\/ccjm.81a.13158","article-title":"Identifying statin-associated autoimmune necrotizing myopathy","volume":"81","author":"Albayda","year":"2014","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"2025041110174981500_luaf037-B13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2025041110174981500_luaf037-B14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.24642","article-title":"The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy","volume":"52","author":"Chung","year":"2015","journal-title":"Muscle Nerve"},{"issue":"1","key":"2025041110174981500_luaf037-B15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2021","journal-title":"J Med Virol"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/5\/luaf037\/62780912\/luaf037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/5\/luaf037\/62780912\/luaf037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:26:53Z","timestamp":1744367213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf037\/8097760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,3,27]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf037","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,3,27]]},"article-number":"luaf037"}}